Mallinckrodt Inc patent expiration

1. Xartemis Xr patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6488962 MALLINCKRODT INC Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
Jun, 2020

(4 years ago)

US7976870 MALLINCKRODT INC Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
Jun, 2027

(2 years from now)

US8394408 MALLINCKRODT INC Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
Mar, 2029

(4 years from now)

US8372432 MALLINCKRODT INC Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
Mar, 2029

(4 years from now)

US8668929 MALLINCKRODT INC Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
Mar, 2029

(4 years from now)

US8377453 MALLINCKRODT INC Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
Nov, 2029

(5 years from now)

US8597681 MALLINCKRODT INC Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
Dec, 2030

(6 years from now)

US8980319 MALLINCKRODT INC Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
Dec, 2030

(6 years from now)

US8741885 MALLINCKRODT INC Gastric retentive extended release pharmaceutical compositions
May, 2032

(7 years from now)

US8992975 MALLINCKRODT INC Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
May, 2032

(7 years from now)

US8658631 MALLINCKRODT INC Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
May, 2032

(7 years from now)

US9050335 MALLINCKRODT INC Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
May, 2032

(7 years from now)

US9468636 MALLINCKRODT INC Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
May, 2032

(7 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Mar 11, 2017

Drugs and Companies using ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE ingredient

Market Authorisation Date: 11 March, 2014

Treatment: Method of treating patients with gastric retentive dosage form; Management of acute pain in patients requiring opioid analgesia

Dosage: TABLET, EXTENDED RELEASE

More Information on Dosage

XARTEMIS XR family patents

Family Patents